Kevin Koch, the President and CEO of Edgewise Therapeutics , Inc. (NASDAQ:EWTX), a biotechnology company with a market capitalization of $2.5 billion, recently executed a series of stock transactions, ...
Chief Communications and Public Affairs Officer Cristal N. Downing recently sold shares of the company, according to a filing with the Securities and Exchange Commission. On February 6, 2025, Downing ...
On January 8, 2025, the Securities and Exchange Commission's (SEC) Division of Investment Management (Division) issued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback